InsidersTradesSigma
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the detailed record of transactions filed by Skibsted Russell. Officer active across 2 companies, notably Alimera Sciences INC. In total, 5 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €15k. Activity tracked since 9 January 2023. The latest transaction was disclosed on 30 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
SKIBSTED RUSSELL is Chief Financial Officer at Processa Pharmaceuticals, Inc. and Chief Financial Officer & SVP at Alimera Sciences INC. This declarant has 5 filings in total, and across the 5 most recent sampled filings the activity is acquisition, with EUR 15102 of buys and no sells, between 2023-01-10 and 2026-05-01.